Negative symptoms in schizophrenia - A review

Nordic Journal of Psychiatry

Volumn 62, Issue 5, 2008, Pages 334-341

  Makinen J ^a   Miettunen, J ^a   Isohanni, M ^a   Koponen, H ^b  

^a UNIVERSITY OF OULU   (Finland)

^b UNIVERSITY OF EASTERN FINLAND   (Finland)

Author keywords

Negative symptoms; Persistence; Prognosis; Schizophrenia; Treatment

Indexed keywords

AMISULPRIDE; ANTICONVULSIVE AGENT; ARIPIPRAZOLE; ATYPICAL ANTIPSYCHOTIC AGENT; CHLORPROMAZINE; CLOZAPINE; ESTROGEN; HALOPERIDOL; NEUROLEPTIC AGENT; OLANZAPINE; PERPHENAZINE; QUETIAPINE; RISPERIDONE; ZOTEPINE;

CLINICAL PROTOCOL; COPING BEHAVIOR; DAILY LIFE ACTIVITY; DISEASE SEVERITY; DRUG DOSE TITRATION; DRUG EFFICACY; DRUG MEGADOSE; EXTRAPYRAMIDAL SYMPTOM; FAMILY THERAPY; HUMAN; HYPERPROLACTINEMIA; LONG TERM CARE; MEDLINE; NEGATIVE SYNDROME; NEUROIMAGING; PREVALENCE; PROGNOSIS; PSYCHOEDUCATION; PSYCHOSIS; PSYCHOSOCIAL CARE; PSYCINFO; QT INTERVAL; QUALITY OF LIFE; REVIEW; SCHIZOPHRENIA; SIDE EFFECT; UNSPECIFIED SIDE EFFECT;

BRAIN; COGNITION DISORDERS; HUMANS; MAGNETIC RESONANCE IMAGING; MENTAL DISORDERS; MOOD DISORDERS; PROGNOSIS; PSYCHOANALYTIC THERAPY; QUALITY OF LIFE; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY;

EID: 52649164141     PISSN: 08039488     EISSN: 15024725     Source Type: Journal    
DOI: 10.1080/08039480801959307     Document Type: Review

References (84)

1. Saha, S., Chant, D., Welham, J. and McGrath, J. (2005) A systematic review of the prevalence of schizophrenia. PLoS Medicine, 2, p. e141.
2. Lauronen, E., Miettunen, J., Veijola, J., Karhu, M., Jones, PB and Isohanni, M. (2007) Outcome and its predictors in schizophrenia within the Northern Finland 1966 birth cohort. Eur Psychiatry, 22, pp. 129-136.
3. Sass, H. (1989) The historical evolution of the concept of negative symptoms in schizophrenia. Br J Psychiatry, 155, pp. 26-31.
4. Kraepelin, E. (1919) Demential praecox and paraphrenia, ES Livingston, Barclay RM, trans. Edinburgh
5. Crow, TJ. (1985) The two-syndrome concept: Origins and current status. Schizophr Bull, 11, pp. 471-485.
6. Carpenter, WT, Heinrichs, DW and Alphs, LD. (1985) Treatment of negative symptoms. Schizophr Bull, 11, pp. 440-452.
7. Kirkpatrick, B., Fenton, WS, Carpenter, WT and Marder, SR. (2006) The NIMH-MATRICS consensus statement on negative symptoms. Schizophr Bull, 32, pp. 214-219.
8. Rami'rez, N., Arranz, B., Sa'nchez, J., Centeno, M. and San, L. (2006) Depression in schizophrenia, can it be treated? A review of the evidence. Curr Psychiatry Rev, 2, pp. 371-379.
9. Emsley, R., Rabinowitz, J. and Torreman, M. (2003) The factor structure for the Positive and Negative Syndrome Scale (PANSS) in recent-onset psychosis. Schizophr Res, 61, pp. 47-57.
10. Salokangas, RKR. (1997) Structure of schizophrenic symptomatology and its changes over time: Prospective factor-analytical study. Acta Psychiatr Scand, 95, pp. 32-39.
11. Bottlender, R., Sato, T., Groll, C., Jager, M., Kunze, I. and Moller, H-J. (2003) Negative symptoms in depressed and schizophrenic patients: How do they differ?. J Clin Psychiatry, 64, pp. 954-958.
12. Kirkpatrick, B. and Fischer, B. (2006) Subdomains within the negative symptoms of schizophrenia: Commentary. Schizophr Bull, 32, pp. 246-249.
13. Blanchard, JJ and Cohen, AS. (2006) The structure of negative symptoms within schizophrenia: Implications for assessment. Schizophr Bull, 32, pp. 238-245.
14. Chaturvedi, SK, Prasad Rao, G, John Mathai, P, Sarmukaddam, S. and Gopinath, PS. (1985) Negative symptoms in schizophrenia and depression. Indian J Psychiatry, 27, pp. 237-241.
15. Alexander, JP and Mathai, JP. (1988) The negative symptoms in chronic schizophrenia. Indian J Psychiatry, 11, pp. 33-42.
16. Winograd-Gurvich, C., Fitzgerald, PB, Georgiou-Karistianis, N., Bradshaw, JL and White, OB. (2006) Negative symptoms: A review of schizophrenia, melancholic depression and Parkinson's disease. Brain Res Bull, 70, pp. 312-321.
17. Carpenter, WT, Heinrichs, DW and Wagman, AM. (1988) Deficit and non-deficit forms of schizophrenia: The concept. Am J Psychiatry, 145, pp. 578-583.
18. Husted, JA, Beiser, M. and Iacono, WG. (1992) Negative symptoms and the early course of schizophrenia. Psychiatry Res, 43, pp. 215-222.
19. Malla, AK, Takhar, JJ, Norman, RMG, Manchanda, R., Cortese, L. Haricharan, R. et al. (2002) Negative symptoms in first episode non-affective psychosis. Acta Psychiatr Scand, 105, pp. 431-439.
20. Malla, AK, Norman, RGM, Takhar, J., Manchanda, R., Townsend, L. Scholten, D. et al. (2004) Can patients at risk for persistent negative symptoms be identified during their first episode of psychosis. J Nerv Ment Dis, 192, pp. 455-463.
21. Buchanan, RW (2006) Persistent negative symptoms in schizophrenia: An overview. Schizophr Bull
22. Kirkpatrick, B., Kopelowicz, A., Buchanan, RW and Carpenter Jr, WT (2000) Assessing the efficacy of treatments for the deficit syndrome of schizophrenia. Neuropsychopharmacology, 22, pp. 303-310.
23. Kimhy, D., Yale, S., Goetz, RR, McFarr, LM and Malaspina, D. (2006) The factorial structure of the schedule for the deficit syndrome in schizophrenia. Schizophr Bull, 32, pp. 274-278.
24. Kirkpatrick, B., Buchanan, RW, McKenney, PD, Alphs, LD and Carpenter Jr, WT (1989) The Schedule for the Deficit syndrome: An instrument for research in schizophrenia. Psychiatry Res, 30, pp. 119-123.
25. Kirkpatrick, B., Buchanan, RW, Ross, DE and Carpenter Jr, WT (2001) A separate disease within the syndrome of schizophrenia. Arch Gen Psychiatry, 58, pp. 165-171.
26. Lader, M. (2000) Rating scales in schizophrenia - A review of their usefulness for assessing atypical antipsychotics. CNS Drugs, 14, pp. 23-32.
27. Andreasen, NC. (1982) Negative symptoms in schizophrenia: Definition and reliability. Arch Gen Psychiatry, 39, pp. 784-788.
28. Andeasen, NC, Carpenter, WT, Kane, JM, Lasser, RA, Marder, SR and Weinberger, DR. (2005) Remission in schizophrenia: Proposed criteria and rationale for consensus. Am J Psychiatry, 162, pp. 441-449.
29. Kay, SR, Opler, LA and Lindenmayer, JP. (1988) Reliability and validity of the Positive and Negative Syndrome Scale for schizophrenia. Psychiatry Res, 23, pp. 99-110.
30. Selten, J-P, Wiersma, D. and van den Bosch, R. (2000) Distress attributed to negative symptoms in schizophrenia. Schizophr Bull, 26, pp. 737-744.
31. Bottlender, R., Wegner, U., Wittmann, J., Strauß A. and Möller, H-J. (1999) Deficit syndromes in schizophrenic patients 15 years after their first hospitalisation: Preliminary results of a follow-up study. Eur Arch Psychiatry Clin Neurosci, 249, pp. 27-36.
32. Arajärvi, R., Varilo, T., Haukka, J., Suvisaari, J., Suokas, J. Juvonen, H. et al. (2006) Affective flattening and alogia associate with the familial form of schizophrenia. Psychiatry Res, 141, pp. 161-172.
33. Eaton, WW, Thara, R., Federman, B., Melton, B. and Liang, K-Y. (1995) Structure and course of positive and negative symptoms in schizophrenia. Arch Gen Psychiatry, 52, pp. 127-134.
34. Herbener, ES and Harrow, M. (2001) Longitudinal assessment of negative symptoms in schizophrenia/schizoaffective patients, other psychotic patients, and depressed patients. Schizophr Bull, 27, pp. 527-537.
35. Pogue-Geile, MF and Zubin, J. (1988) Negative symptomatology and schizophrenia: A conceptual and empirical review. Int J Ment Health, 16, pp. 3-45.
36. Andreasen, N., Nasrallah, HA, Dunn, V., Olson, SC, Grove, WM Ehrhardt, JC et al. (1986) Structural abnormalities in the frontal system in schizophrenia. A magnetic resonance imaging study. Arch Gen Psychiatry, 43, pp. 136-144.
37. Sigmundsson, T., Suckling, J., Maier, M., Williams, SCR, Bullmore, ET Greenwood, KE et al. (2001) Structural abnormalities in frontal, temporal, and limbic regions and interconnecting white matter tracts in schizophrenic patients with prominent negative symptoms. Am J Psychiatry, 158, pp. 234-243.
38. Anderson, JE, Wible, CG, McCarley, RW, Jakab, M., Kasai, K. and Shenton, ME. (2002) An MRI study of temporal lobe abnormalities and negative symptoms in chronic schizophrenia. Schizophr Res, 58, pp. 123-134.
39. Sanfilipo, M., Lafargue, T., Rusinek, H., Arena, L., Loneragan, C. Lautin, A. et al. (2000) Volumetric measure of the frontal and temporal lobe regions in schizophrenia: Relationship to negative symptoms. Arch Gen Psychiatry, 57, pp. 471-480.
40. Wolkin, A., Choi, SJ, Szilagyi, S., Sanfilipo, M., Rotrosen, JP and Lim, KO. (2003) Inferior frontal white matter anisotropy and negative symptoms of schizophrenia: A diffusion tensor imaging study. Am J Psychiatry, 160, pp. 572-574.
41. Roth, RM, Saykin, LA, McAllister, AJ and Vidaver, TW. (2004) Apathy in schizophrenia. reduced frontal lobe volume and neuropsychological deficits. Am J Psychiatry, 161, pp. 157-159.
42. Chua, SE and McKenna, PJ. (1995) Schizophrenia - A brain disease? A critical review of structural and functional cerebral abnormality in the disorder. Br J Psychiatry, 166, pp. 563-582.
43. Honey, GD, Pomarol-Clotet, E., Corlett, PR, Honey, RAE, McKenna, PJ McKenna, ET et al. (2005) Functional dysconnectivity in schizophrenia associated with attentional modulation of motor function. Brain, 128, pp. 2597-2611.
44. Mucci, A., Galderisi, S., Kirkpatrick, B., Bucci, P., Volpe, U. Merlotti, E. et al. (2007) Double dissociation of N1 and P3 abnormalities in deficit and nondeficit schizophrenia. Schizophr Res, 92, pp. 252-261.
45. Potkin, SG, Alva, G., Fleming, K., Anand, R., Keator, D. Carreon, D. et al. (2002) A PET study of the pathophysiology of negative symptoms in schizophrenia. Am J Psychiatry, 159, pp. 227-237.
46. Min, SK, An, SK, Jon, DI and Lee, JD. (1999) Positive and negative symptoms and regional cerebral perfusion in antipsychotic-naïve schizophrenic patients: A high-resolution SPECT study. Psychiatry Res, 90, pp. 159-168.
47. Stahl, SM and Buckley, PF. (2007) Negative symptoms of schizophrenia: A problem that will not go away. Acta Psychiatric Scand, 115, pp. 4-11.
48. Kasper, S. (2006) Optimisation of long-term treatment in schizophrenia. Treating the true spectrum of symptoms. Eur Neuropsychopharmacol, 16, pp. 135-141.
49. Goldberg, SC. (1985) Negative and deficit symptoms in schizophrenia do respond to neuroleptics. Schizophr Bull, 11, pp. 453-456.
50. King, DJ. (1998) Drug treatment of the negative symptoms of schizophrenia. Eur Neuropsychopharmacol, 8, pp. 33-42.
51. Möller, HJ. (1999) Atypical neuroleptics: A new approach in the treatment of negative symptoms. Eur Arch Psychiatry Clin Neurosci, 249, pp. 99-107.
52. Möller, HJ. (2003) Management of the negative symptoms of schizophrenia: New treatment options. CNS Drugs, 17, pp. 793-823.
53. Javitt, DC. (2001) Management of negative symptoms of schizophrenia. Curr Psychiatry Rep, 3, pp. 413-417.
54. Davis, JM, Chen, N. and Glick, ID. (2003) A Meta-analysis of the efficacy of second-generation antipsychotics. Arch Gen Psychiatry, 60, pp. 553-564.
55. Tuunainen, A., Wahlbeck, K. and Gilbody, S. (2002) Newer atypical antipsychotic medication in comparison to clozapine: A systematic review of randomized trials. Schizophr Res, 56, pp. 1-10.
56. El-Sayeh, HG and Morganti, C. (2006) Aripiprazole for schizophrenia. Cochrane Database of Syst Rev
57. Thornley, B., Rathbone, J., Adams, CE and Awad, G. (2003) Chlorpromazine versus placebo for schizophrenia. Cochrane Database of Syst Rev
58. Wahlbeck, K., Cheine, MV and Essali, A. (1999) Clozapine versus typical neuroleptic medication for schizophrenia. Cochrane Database of Syst Rev
59. Tuunainen, A., Wahlbeck, K. and Gilbody, SM (2000) Newer atypical antipsychotic medication versus clozapine for schizophrenia. Cochrane Database of Syst Rev
60. Duggan, L., Fenton, M., Rathbone, J., Dardennes, R., El-Dosoky, A. and Indran, S. (2005) Olanzapine for schizophrenia. Cochrane Database of Syst Rev
61. Hartung, B., Wada, M., Laux, G. and Leucht, S. (2005) Perphenazine for schizophrenia. Cochrane Database of Syst Rev
62. Srisurapanont, M., Maneeton, B. and Maneeton, N. (2004) Quetiapine for schizophrenia. Cochrane Database of Syst Rev
63. Hunter, RH, Joy, CB, Kennedy, E., Gilbody, SM and Song, F. (2003) Risperidone versus typical antipsychotic medication for schizophrenia. Cochrane Database of Syst Rev
64. Gilbody, SM, Bagnall, AM, Duggan, L. and Tuunainen, A. (2000) Risperidone versus other atypical antipsychotic medication for schizophrenia. Cochrane Database of Syst Rev
65. DeSilva, P., Fenton, M. and Rathbone, J. (2006) Zotepine for schizophrenia. Cochrane Database of Syst Rev
66. Buckley, PF and Stahl, SM. (2007) Pharmacological treatment of negative symptoms of schizophrenia: Therapeutic opportunity or Cul-de-sac?. Acta Psychiatr Scand, 115, pp. 93-100.
67. Keefe, RSE, Bilder, RM, Davis, SM, Harvey, PD, Palmer, BW Gold, JM et al. (2007) Neurocognitive effects of antipsychotic medications in patients with chronic schizophrenia in the CATIE trial. Arch Gen Psychiatry, 64, pp. 633-647.
68. Möller, HJ. (2004) Non-neuroleptic approaches to treating negative symptoms in schizophrenia. Eur Arch Psychiatry Clin Neurosci, 254, pp. 108-116.
69. Lauriello, J., Lenroot, R. and Bustillo, JR. (2003) Maximizing the synergy between pharmacotherapy and psychosocial therapies for schizophrenia. Psychiatr Clin North Am, 26, pp. 191-211.
70. Pharoah, F., Mari, J., Rathbone, J. and Wong, W. (2006) Family intervention for schizophrenia. Cochrane Database of Syst Rev
71. Pekkala, E. and Merinder, L. (2002) Psychoeducation for schizophrenia. Cochrane Database of Syst Rev
72. Jeffery, DP, Ley, A., McLaren, S. and Siegfried, N. (2000) Psychosocial treatment programmes for people with both severe mental illness and substance misuse. Cochrane Database of Syst Rev
73. Buckley, LA and Pettit, T. (2007) Supportive therapy for schizophrenia Cochrane Database of Syst Rev
74. Rathod, S. and Turkington, D. (2005) Cognitive-behaviour therapy for schizophrenia: A review. Curr Opin Psychiatry, 18, pp. 159-163.
75. Arndt, S., Andreasen, NC, Flaum, M., Miller, D. and Nopoulos, P. (1995) A longitudinal study of symptom dimensions in schizophrenia. Prediction and patterns of change. Arch Gen Psychiatry, 52, pp. 352-360.
76. Hwu, HG, Tan, H., Chen, CC and Yeh, LL. (1995) Negative symptoms at discharge and outcome in schizophrenia. Br J Psychiatry, 166, pp. 61-67.
77. Tek, C., Kirkpatrick, B. and Buchanan, RW. (2001) A five-year follow-up study of deficit and nondeficit schizophrenia. Schizophr Res, 49, pp. 253-260.
78. Alptekin, K., Erkoc, S., Gogus, AK, Kultur, S., Mete, L. Ucok, A. et al. (2005) Disability in schizophrenia: Clinical correlates and prediction over 1-year follow-up. Psychiatry Res, 135, pp. 103-111.
79. Lindenmayer, J-P, Yeshiva, U., Kay, SR and Friedman, C. (1986) Negative and positive schizophrenic syndromes after the acute phase: A prospective follow-up. Compr Psychiatry, 27, pp. 276-286.
80. Kay, SR and Murrill, LM. (1990) Predicting outcome of schizophrenia: Significance of symptom profiles and outcome dimensions. Compr Psychiatry, 31, pp. 91-102.
81. Fenton, WS and McGlashan, TH. (1991) Natural history of schizophrenia subtypes: II. Positive and negative symptoms and long-term course. Arch Gen Psychiatry, 48, pp. 978-986.
82. Ho, B., Nopoulos, P., Flaum, M., Arndt, S. and Andreasen, NC. (1998) Two-year outcome in first-episode schizophrenia: Predictive value of symptoms for quality of life. Am J Psychiatry, 155, pp. 1196-1201.
83. Mueser, KT, Douglas, MS, Bellack, AS and Morrison, RL. (1991) Assessment of enduring deficit and negative symptom subtypes in schizophrenia. Schizophr Bull, 17, pp. 565-582.
84. Hwu, H-G, Chen, C-H, Whang, T-J, Liu, C-H, Cheng, JJ Lin, S-K et al. (2002) Symptom patterns and subgrouping of schizophrenic patients: Significance of negative symptoms assessed on admission. Schizophr Res, 56, pp. 105-119.